novo nordisk semaglutide alzheimer trial says semaglutide, the drug used in Wegovy and Ozempic, does not slow Alzheimer's progression, despite early real-world signals that prompted two major Evoke trials involving more than 3,800 participants aged GLP-1 Drug Fails to Quell

Ozempic is primarily celebrated for its effectiveness in managing type 2 diabetes and aiding weight loss

median age 50 years, 72% women) had ended treatment within one year, with 18% discontinuing by 3 months, 31% by 6 months, and 42% by 9 months

Among them, the PPAR/ subtype is considered to be an important pharmacological target for the treatment of diabetes and its related diseases in many studies

Even though the test is widely available, most medical experts dont recommend that you use it

Nausea Management: Some research and anecdotal evidence suggest that B12 may help reduce the gastrointestinal side effects, like mild nausea, that can occur during the initial stages of treatment